MOTS-C

MOTS-C (Mitochondrial Open Reading Frame of the Twelve S rRNA Type-C) is a peptide encoded within the mitochondrial genome rather than the nuclear genome. This makes it part of a recently discovered class of mitochondria-derived peptides (MDPs) that serve as signaling molecules between mitochondria and the rest of the cell. MOTS-C is primarily recognized for its potent activation of AMPK (AMP-activated protein kinase), the master metabolic sensor that regulates energy balance at the cellular level.

When AMPK is activated by MOTS-C, a cascade of metabolic benefits follows: glucose uptake increases, fatty acid oxidation is upregulated, and mitochondrial biogenesis is stimulated. This translates to improved insulin sensitivity, more efficient fat metabolism, and greater metabolic flexibility, the ability to seamlessly switch between fuel sources depending on demand. These effects make MOTS-C particularly relevant for individuals facing age-related metabolic decline.

Under conditions of metabolic stress, MOTS-C undergoes nuclear translocation, moving from the mitochondria into the cell nucleus where it directly influences gene expression related to antioxidant defense and cellular adaptation. This unique dual-compartment activity positions MOTS-C as both a metabolic optimizer and a stress-resilience factor, supporting not only physical energy but also cognitive performance through enhanced neuronal metabolism.

MOTS-C was first identified in 2015 by researchers at the University of Southern California who discovered that the mitochondrial genome encodes bioactive peptides with systemic signaling functions. This finding challenged the long-held view that mitochondria serve only as passive energy factories and revealed an entirely new layer of intracellular communication.

Subsequent research has shown that MOTS-C levels decline with age and that this decline correlates with increased metabolic dysfunction, insulin resistance, and reduced exercise capacity. Animal studies have demonstrated that MOTS-C administration can reverse diet-induced obesity, improve glucose tolerance, and enhance physical performance. Human studies are underway, with early data supporting its role in metabolic optimization and cellular stress resilience. MOTS-C is now considered a key molecule in the emerging field of mitochondrial-derived signaling peptides.